Business Description
BioRegenx Inc
NAICS : 923120
SIC : 7372
ISIN : US31772N1000
Description
BioRegenx Inc is redefining health intelligence with new patented technologies and artificial intelligence. Its specialize in developing intellectual property (IP) and are engaged in regenerative biotherapeutics, anti-aging, artificial intelligence (AI) for healthcare and bioinformatics for public and private transportation. The primary focus involves acquiring or developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing extensive datasets.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | -13.29 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -26 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.86 | |||||
| 9-Day RSI | 38.34 | |||||
| 14-Day RSI | 44.38 | |||||
| 3-1 Month Momentum % | -50.73 | |||||
| 6-1 Month Momentum % | -69.89 | |||||
| 12-1 Month Momentum % | -32.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.11 | |||||
| Quick Ratio | 0.06 | |||||
| Cash Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.1 | |||||
| Shareholder Yield % | -9.18 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.19 | |||||
| Operating Margin % | 163.42 | |||||
| Net Margin % | 226.35 | |||||
| FCF Margin % | -90.49 | |||||
| ROE % | -21.2 | |||||
| ROA % | -16.84 | |||||
| ROIC % | -11.15 | |||||
| 3-Year ROIIC % | -441.67 | |||||
| ROC (Joel Greenblatt) % | -533.46 | |||||
| ROCE % | -20.11 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 2.77 | |||||
| PE Ratio without NRI | 2.77 | |||||
| PB Ratio | 1.38 | |||||
| Price-to-Free-Cash-Flow | 2.77 | |||||
| Price-to-Operating-Cash-Flow | 2.77 | |||||
| EV-to-EBIT | -8.45 | |||||
| EV-to-EBITDA | -94.52 | |||||
| EV-to-Revenue | -18.43 | |||||
| EV-to-FCF | 22.99 | |||||
| Price-to-Projected-FCF | 1.38 | |||||
| Earnings Yield (Greenblatt) % | -11.83 | |||||
| FCF Yield % | 5.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BRGX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioRegenx Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | -0.831 | ||
| EPS (TTM) ($) | 0.005 | ||
| Beta | -3.08 | ||
| 3-Year Sharpe Ratio | 0.43 | ||
| 3-Year Sortino Ratio | 1.76 | ||
| Volatility % | 154.91 | ||
| 14-Day RSI | 44.38 | ||
| 14-Day ATR ($) | 0.001037 | ||
| 20-Day SMA ($) | 0.014256 | ||
| 12-1 Month Momentum % | -32.25 | ||
| 52-Week Range ($) | 0.0101 - 0.085 | ||
| Shares Outstanding (Mil) | 956.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioRegenx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioRegenx Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioRegenx Inc Frequently Asked Questions
What is BioRegenx Inc(BRGX)'s stock price today?
The current price of BRGX is $0.01. The 52 week high of BRGX is $0.09 and 52 week low is $0.01.
When is next earnings date of BioRegenx Inc(BRGX)?
The next earnings date of BioRegenx Inc(BRGX) is .
Does BioRegenx Inc(BRGX) pay dividends? If so, how much?
BioRegenx Inc(BRGX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers